5 min

Is Big Pharma Transparent Enough‪?‬ Knowledge@HEC

    • Affaires

Are the efforts of transparency by the pharmaceutical industry sufficient to regain the trust of the world population? The COVID-19 pandemic has taken the world hostage since March 2020, yet there is hope that this health crisis may be vanquished this year, thanks to the approved vaccines by pharmaceutical companies such as Pfizer/BioNtech, Moderna and AstraZeneca. While there are ongoing vaccination drives, there are nonetheless doubts about these newly-developed vaccines, which compromises the effectiveness of vaccination campaigns already underway. HEC Paris professor Professor Vedran Capkun tells us why transparency is critical in this current context. He explains what the outcome of the production of these vaccines represents for the pharmaceutical industry. 
Hosted on Acast. See acast.com/privacy for more information.

Are the efforts of transparency by the pharmaceutical industry sufficient to regain the trust of the world population? The COVID-19 pandemic has taken the world hostage since March 2020, yet there is hope that this health crisis may be vanquished this year, thanks to the approved vaccines by pharmaceutical companies such as Pfizer/BioNtech, Moderna and AstraZeneca. While there are ongoing vaccination drives, there are nonetheless doubts about these newly-developed vaccines, which compromises the effectiveness of vaccination campaigns already underway. HEC Paris professor Professor Vedran Capkun tells us why transparency is critical in this current context. He explains what the outcome of the production of these vaccines represents for the pharmaceutical industry. 
Hosted on Acast. See acast.com/privacy for more information.

5 min

Classement des podcasts dans Affaires

Génération Do It Yourself
Matthieu Stefani | Orso Media
Ressentir
Jessica Troisfontaine
Sans Permission
Sans Permission - By Yomi & Oussama
Émotions (au travail)
Louie Media
Finary Talk
Finary
L'Art de la Gestion Patrimoniale
Bonnet Doyen Conseil : Épargner, Investir, Entreprendre, Immobilier, Impôts